e-learning
resources
Paris 2018
Monday, 17.09.2018
Clinical aspects of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK)
I. Armstrong (Sheffield, United Kingdom), C. Billings (Sheffield, United Kingdom), S. Clayton (Sheffield, United Kingdom), J. Yorke (Manchester, United Kingdom), C. Harries (London, United Kingdom), D. Kiely (Sheffield, United Kingdom)
Source:
International Congress 2018 – Clinical aspects of pulmonary hypertension
Session:
Clinical aspects of pulmonary hypertension
Session type:
Thematic Poster
Number:
3085
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Armstrong (Sheffield, United Kingdom), C. Billings (Sheffield, United Kingdom), S. Clayton (Sheffield, United Kingdom), J. Yorke (Manchester, United Kingdom), C. Harries (London, United Kingdom), D. Kiely (Sheffield, United Kingdom). Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK). 3085
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Effects of pulmonary rehabilitation (PR) in idiopathic pulmonary arterial hypertension (PAHI)
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 589-596
Year: 2012
Pulmonary arterial hypertension and general practitioners: Difficulties are mainly due to a lack of knowledge
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013
Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
An evaluation of outcomes for patients with pulmonary hypertension (PH) incorporated into a standard UK pulmonary rehabilitation (PR) programme
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Pulmonary rehabilitation in the United States: the American Association of Cardiovascular and Pulmonary Rehabilitation national pulmonary rehabilitation survey
Source: International Congress 2014 – State of the nation(s) in terms of pulmonary rehabilitation: results from the Canadian, American and European pulmonary rehabilitation survey studies
Year: 2014
Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Pulmonary function is associated with pulmonary artery systolic pressure in the general population: The Rotterdam study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014
Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals
Source: Eur Respir Rev 2010 19: 272-278
Year: 2010
Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Pulmonary embolism in Spain: Differences between men and women
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept